EBM, Landmark Research
Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries
EBM, Journal Club
Do you ever give NSAID’s to patients with cardiomyopathy? Usually not, and here is evidence supporting why we don’t. But are there some NSAID’s that have less unfavorable outcomes?
Rifaximin Plus Lactulose Versus Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
EBM, Landmark Research
Lactulose is widely used for treatment of hepatic encephalopathy because it is effective, cheap, and widely available. So is there any benefit to using Rifaximin in patients with hepatic encephalopathy? Here are some questions to answer when reviewing this article…
Time-to-Furosemide Treatment and Mortality in Patients Hospitalized with Acute Heart Failure
EBM, Journal Club
Key Discussion Points: Early treatment of acute heart failure with loop diuretics lowers mortality despite initial mortality risk, and this treatment strategy might be even more effective in high-risk AHF patients Earlier treatment/identification of acute heart failure relied heavily on…
Second Wednesday: Fall / AMA / Death
Night Float Curriculum
This post is protected. Please log in to view content.
Second Tuesday: Seizure
Night Float Curriculum
This post is protected. Please log in to view content.
Second Monday: Hyperglycemia / Hypoglycemia
Night Float Curriculum
This post is protected. Please log in to view content.
Second Sunday: Constipation / Nausea / Oliguria
Night Float Curriculum
This post is protected. Please log in to view content.
Second Saturday: Pain / Insomnia / Agitation
Night Float Curriculum
This post is protected. Please log in to view content.
Second Friday: Bleeding / Transfusion
Night Float Curriculum
This post is protected. Please log in to view content.